1 / 1

Supplemental Data Figure 1

A. 1000. 8000. 800. hs-cTnT (corrected) [ng/L]. 6000. 600. 4000. 400. 0. 2000. 4000. 6000. 8000. hs-cTnT (original) [ng/L]. B. 200. 2000. 0. 0. hs-cTnT (corrected) [ng/L]. 0. 200. 400. 600. 800. 1000. hs-cTnT (original) [ng/L]. C. 100. 80.

kylee
Télécharger la présentation

Supplemental Data Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A 1000 8000 800 hs-cTnT (corrected) [ng/L] 6000 600 4000 400 0 2000 4000 6000 8000 hs-cTnT (original) [ng/L] B 200 2000 0 0 hs-cTnT (corrected) [ng/L] 0 200 400 600 800 1000 hs-cTnT (original) [ng/L] C 100 80 hs-cTnT (corrected) [ng/L] 60 40 20 0 20 40 60 80 100 0 hs-cTnT (original) [ng/L] Supplemental Data Figure 1 Hs-cTnT concentrations measured with lot #163704 (original, x axes) plotted against corrected hs-cTnT concentrations obtained after the adjusted standardization procedure (corrected, y axes). Corrected values were used for all prognostic assessments. (A) All patients, (B) values below 1000 ng/L, (C) values below 100 ng/L.

More Related